MedTrace Logo

Early Controlled Loading on Conservative Treated Achilles Tendon Ruptures

NCT02805751 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-08-10

No results posted yet for this study

Summary

The purpose of this study is to measure the mechanical properties of the tendon after conservative treated Achilles tendon ruptures with or without early controlled loading. This is done in a randomized trial and the mechanical properties are measured using roentgen stereometric analysis (RSA).

The hypothesis is that early weightbearing improves mechanical properties of conservative treated Achilles tendon ruptures without causing elongation of the tendon.

Conditions

  • Tendon Injuries
  • Soft Tissue Injuries
  • Achilles Tendon Rupture

Interventions

DEVICE

Early loading on a training pedal

The patients will perform early loading by using a special training pedal for 5 weeks, starting 2 weeks after the rupture. The patients will remove the walker and train twice a day on this pedal.

OTHER

Tendon strain exercises

The patients will perform tendon strain exercises 3 times each day from 2 weeks after the rupture.

OTHER

Early weight bearing

The patients are allowed to bear weight as much as tolerated in the walker from day 1.

Sponsors & Collaborators

  • University Hospital, Linkoeping

    collaborator OTHER

  • Linkoeping University

    lead OTHER_GOV

Principal Investigators

  • Per Aspenberg, MD, PhD · Linkoeping University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-11-30
Completion
2019-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02805751 on ClinicalTrials.gov